shai izraeli
shai izraeli
Professor, Head of the Division of Pediatric Hematology Oncology Schneider Children's Medical Center
Verified email at
Cited by
Cited by
Childhood acute lymphoblastic leukemia: progress through collaboration
CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ...
Journal of Clinical Oncology 33 (27), 2938-2948, 2015
The MLL recombinome of acute leukemias in 2017
C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ...
Leukemia 32 (2), 273-284, 2018
The MLL recombinome of acute leukemias in 2013
C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ...
Leukemia 27 (11), 2165-2176, 2013
New insights to the MLL recombinome of acute leukemias
C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ...
Leukemia 23 (8), 1490-1499, 2009
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non–small-cell lung carcinoma
D Lebanony, H Benjamin, S Gilad, M Ezagouri, A Dov, K Ashkenazi, ...
Journal of clinical oncology 27 (12), 2030-2037, 2009
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ...
Journal of Experimental Medicine 208 (5), 901-908, 2011
The landscape of somatic mutations in Down syndrome–related myeloid disorders
K Yoshida, T Toki, Y Okuno, R Kanezaki, Y Shiraishi, A Sato-Otsubo, ...
Nature genetics 45 (11), 1293-1299, 2013
Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002
J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ...
Journal of clinical oncology 32 (3), 174-184, 2014
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ...
The Lancet 372 (9648), 1484-1492, 2008
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report …
L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ...
Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010
The public repository of xenografts enables discovery and randomized phase II-like trials in mice
EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ...
Cancer cell 29 (4), 574-586, 2016
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21
L Rainis, D Bercovich, S Strehl, A Teigler-Schlegel, B Stark, J Trka, ...
Blood 102 (3), 981-986, 2003
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ...
Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
S Malinge, S Izraeli, JD Crispino
Blood, The Journal of the American Society of Hematology 113 (12), 2619-2628, 2009
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children …
G Cario, M Zimmermann, R Romey, S Gesk, I Vater, J Harbott, ...
Blood, The Journal of the American Society of Hematology 115 (26), 5393-5397, 2010
IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
M Stanulla, E Dagdan, M Zaliova, A Möricke, C Palmi, G Cazzaniga, ...
Journal of Clinical Oncology 36 (12), 1240-1249, 2018
The expression of three genes in primary non–small cell lung cancer is associated with metastatic spread to the brain
H Grinberg-Rashi, E Ofek, M Perelman, J Skarda, P Yaron, M Hajdúch, ...
Clinical Cancer Research 15 (5), 1755-1761, 2009
The SIL gene is required for mouse embryonic axial development and left–right specification
S Izraeli, LA Lowe, VL Bertness, DJ Good, DW Dorward, IR Kirsch, ...
Nature 399 (6737), 691-694, 1999
MiR-125 in normal and malignant hematopoiesis
L Shaham, V Binder, N Gefen, A Borkhardt, S Izraeli
Leukemia 26 (9), 2011-2018, 2012
STIL is required for centriole duplication in human cells
J Vulprecht, A David, A Tibelius, A Castiel, G Konotop, F Liu, F Bestvater, ...
Journal of cell science 125 (5), 1353-1362, 2012
The system can't perform the operation now. Try again later.
Articles 1–20